Samuel Acuff
Samuel Acuff
Dr. Cassandra Gipson - Xylazine
Dr. Cassandra Gipson - Xylazine
Dr. Cassandra Gipson - Xylazine
Monday 11th March 2024
Learn about Xylazine, a new opioid adulterant, from Dr. Cassandra Gipson-Reichardt on 'The Addiction Psychologist'. Understand its impact on health and recovery.
59 minutes
Informative
Empowering
Hopeful
Supportive
Transformative
About this podcast
Author:
Samuel Acuff
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Navigating Alcohol Dependency
Navigating Intimate Relationships
Body & Mind
Links:
Visit site
Episodes:
56 (View all)
Do you want to link to this podcast?
Get the buttons here!Understanding Xylazine: The New Threat in Opioid Addiction
Episode Overview
- Xylazine's emergence in the opioid supply and its potential effects
- The challenges of understanding Xylazine's impacts on individuals and public health
- Research insights into Xylazine's behavioural and physiological effects
- Community engagement for education and outreach on emerging drug trends
- Policy implications and funding challenges in addressing novel adulterants
Persistence is really, really important. This career is full of a lot of no's and criticism, and just finding a way to be comfortable in yourself and know that a rejection doesn't mean that you're bad at this, that you just have to reformulate or try something, maybe tweak it a little differently and also expand your research portfolio.
Picture this: a new substance quietly infiltrates the illicit opioid market, causing a surge in overdose deaths. That's the unsettling reality with Xylazine, a novel adulterant making waves in the drug scene. In this episode of 'The Addiction Psychologist', Dr. Cassandra Gipson-Reichardt, an associate professor at the University of Kentucky, breaks down what Xylazine is, how it works, and why it's becoming so prevalent.
With overdose mortalities linked to Xylazine skyrocketing by over 1000% between 2020 and 2021, understanding this substance is more crucial than ever. Dr. Gipson-Reichardt dives into the emerging literature on Xylazine, offering a comprehensive look at its effects on health and its implications for addiction recovery. She tackles tough questions about the challenges researchers face in studying this drug and the broader impact it has on communities and policy-making.
If you're curious about how new drug adulterants complicate the already complex world of addiction treatment, this episode is a must-listen. The discussion doesn't stop at the science. Dr. Gipson-Reichardt also touches on community outreach efforts aimed at mitigating the damage caused by Xylazine. Her insights provide a multi-faceted view of the problem, making it clear that tackling this issue requires a collaborative approach from researchers, clinicians, and policymakers alike.
Whether you're directly involved in addiction recovery or simply want to stay informed about emerging threats in the drug supply, this episode offers valuable knowledge and thought-provoking perspectives. Tune in to gain a deeper understanding of Xylazine and its far-reaching effects.